ZD1839: targeting the epidermal growth factor receptor in cancer therapy

By Herbst Roy S  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 837-849

Informa Healthcare

Access to resources Recommend Favorite

Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 6, 2009-09 ,pp. : 748-760

Bentham Science Publishers

Access to resources Recommend Favorite

Combining Anti-Epidermal Growth Factor Receptor (EGFR) and Anti-Angiogenic Strategies in Advanced NSCLC: We Should have Known Better…

By  

Current Pharmaceutical Design, Vol. 20, Iss. 24, 2014-05 ,pp. : 3901-3913

Bentham Science Publishers

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor as a Target: Recent Developments in the Search for Effective New Anti-Cancer Agents

By  

Current Drug Targets, Vol. 2, Iss. 2, 2001-06 ,pp. : 117-133

Bentham Science Publishers

Access to resources Recommend Favorite

Downstream intracellular effectors of epidermal growth factor receptor as targets for anticancer therapy

By Milano Amalia   De Rosa Vincenzo   Iaffaioli Rosario Vincenzo   Caponigro Francesco  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 6, 2007-06 ,pp. : 771-782

Informa Healthcare

Access to resources Recommend Favorite